Health
Treasure Global's ZCITY App Signs a Memorandum of Understanding with Malaysia's Leading Healthcare Group, UCSI Hospital, to Pioneer Stem Cell Healthcare Tourism for Indonesia, Hong Kong and Mainland China
- Through this partnership, TGL will further monetize its user base and expects a projected 100%monthly gross profit increase from this partnership - NEW YORK and KUALA LUMPUR, Malaysia, Nov. 1, 2023 /PRNewswire/ -- Treasure Global Inc (NASDAQ: TGL) ("TGL," "Treasure Global" or the "Company"), an...
Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction
The Group is Advancing the Program to a Phase II Clinical Study Data presented at the 2023 Fall Clinical Dermatology Conference HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, Nov. 1, 2023 /PRNewswire/ --Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries,...
Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development Board
Following launch of first-of-its-kind collaboration between Johnson & Johnson Innovation – JLABS andSingapore's Economic Development Board, the Singapore QuickFire Challenge invites innovators to pitch for grant funding from a pool of $100,000 for further development. SINGAPORE, Nov. 1, 2023 /PRN...
Milliken & Company Launches OVIK Health
Company rebrands healthcare business as a strategic enabler SPARTANBURG, S.C., Nov. 1, 2023 /PRNewswire/ -- Today, global diversified manufacturer Milliken & Company unveiled a new brand platform for its healthcare business. OVIK Health, as Milliken Healthcare Products, LLC, will now be known, r...
AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023
* Six posters featuring the Lunit SCOPE suite and new insights into the tumor microenvironment are to be showcased at the SITC 2023 Annual Meeting SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therap...
Jolly Good Inc. Establishes North American Subsidiary: Joint Development of Medical VR for "Apple Vision Pro" with U.S. Experts
~ First Phase: Joint Development of Chronic Pain VR with U.S. Chronic Pain Experts TOKYO, Nov. 1, 2023 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as Jolly Good), which develops and provides medical VR, announces that it has established a North Ame...
SIBIONICS Achieves Milestone: Receiving CE Mark for Its Groundbreaking GS1 Continuous Glucose Monitoring System
SHENZHEN, China, Nov. 1, 2023 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring System (CGM) brand, is delighted to announce that it has received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, fac...
I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023
ROCKVILLE, MD, U.S. and SHANGHAI, China, Nov. 1, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunother...
CStone Announces Strategic Partnership and Exclusive Licensing Agreement with 3SBio for Nofazinlimab (Anti-PD-1 Antibody) in Mainland China
* CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in mainlandChina. CStone to retain the rights to nofazinlimab outside mainland China. * This partnership will combine the strengths of CStone a...
AXA BetterMe Weekend concludes in high note, drawing over 12,000 participants
Two-day carnival inspires physical and mental well-being Allowing citizens to unwind and rejuvenate to become a BetterMe HONG KONG, Nov. 1, 2023 /PRNewswire/ -- AXA BetterMe Weekend, the iconic annual carnival hosted by AXA Hong Kong andMacau (AXA) on 28 and 29 October 2023, was a resounding succ...
Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T
* Anbal-cel targeting DLBCL completes phase 2 trial * Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review * Commercial manufacturing scheduled in 2025 at Korea's only CAR-T GMP facility DAEJEON, South Korea, Nov. 1, 2023 /PRNewswire/ -- Curocell, South Korea ...
Herbalife Survey Reveals More Than Half of Asia Pacific Consumers Find Support Groups Very Important in Their Health and Wellness Journeys
Herbalife Run returns this November to celebrate the power of community for supporting healthy, active living HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released findings from itsAsia Pacific Power of Community Survey,revealing t...
P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns
* 1 in 2 Diabetics and 1 in 10 Pre-diabetics estimated to suffer from Peripheral Neuropathy * Vitamin B Deficiency affects quality of life of ~ 19% of all people with diabetes * #KnowtheSigns leverages Artificial Intelligence to make the invisible condition of Peripheral Neuropathy & Vitami...
New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health
JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- A new report from JPA Health entitled, "One World, One Health: Exploring the Connectability between Human, Animal and Environmental Health," reveals a concerning lack o...
Extracellular Nanoparticles Sourced From Another Species Reverses Biological Age of Rats by More Than 50%
Peer Reviewed Publication: World's first demonstration of cross species epigenetic transfer that significantly reverses biological age by Scientists at Yuvan Research. MOUNTAIN VIEW, Calif., Nov. 1, 2023 /PRNewswire/ -- In a groundbreaking research paper titled"Reversal of Biological Age in Mult...
Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata
LONDON, Nov. 1, 2023 /PRNewswire/ -- Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata. Final results of the study are anticipated to be ...
Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting
SHANGHAI and HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer...
Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S.
WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, announced today at the American Society of Human Genetics (ASHG) Annual Meeting,Nov. 1-5, in Washington details on the commercial and technical momentum it has demonstrated in the last 10 months ...
88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions
SHENZHEN, China, Oct. 31, 2023 /PRNewswire/ -- The 88th China International Medical Equipment Fair (CMEF) officially kicks off onOctober 28 at the Shenzhen World Exhibition & Convention Center. The four-day tradeshow will feature over 10,000 products brought by over 4,000 exhibitors from more tha...
BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures
NEW YORK, Oct. 31, 2023 /PRNewswire/ -- MSQ Ventures ("MSQ") is pleased to announce that its client, BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has entered into an exclusive license agreement with Guangzhou Gloria Biosciences Co., Ltd. (GloriaBio) and an associated investor for the deve...
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 292 media titles]
2024-11-13 09:00Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11